Zacks Small Cap Research – CEO Chat with Dr. Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics
NASDAQ: LABT David Bautz, PhD: Welcome to our next episode in our CEO Chat series. My name is David Bautz. I’m a senior biotechnology analyst here at Zacks Small Cap Research. Joining me today is Dr. Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics (NASDAQ: LABT). Lakewood-Amedex is developing the Bisphosphocin® class of antimicrobials to address unmet needs in the treatment of








